Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up: Annals of Oncology

E. Zucca, L. Arcaini, C. Buske, P.W. Johnson, M. Ponzoni, M. Raderer, U. Ricardi, A. Salar, K. Stamatopoulos, C. Thieblemont, A. Wotherspoon, M. Ladetto, ESMO Guidelines Committee

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)17-29
Number of pages13
JournalAnn. Oncol.
Volume31
Issue number1
DOIs
Publication statusPublished - 2020

Keywords

  • clinical practice guidelines
  • extranodal marginal zone lymphoma (EMZL)
  • marginal zone B-cell lymphoma (MZL)
  • mucosa-associated lymphoid tissue (MALT)
  • nodal marginal zone lymphoma (NMZL)
  • splenic marginal zone lymphoma (SMZL)
  • amoxicillin
  • bendamustine
  • chlorambucil
  • cladribine
  • clarithromycin
  • cyclophosphamide
  • cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine
  • fludarabine
  • metronidazole
  • prednisone
  • proton pump inhibitor
  • rituximab
  • vincristine
  • Article
  • bone marrow biopsy
  • cancer chemotherapy
  • cancer immunotherapy
  • cancer incidence
  • cancer radiotherapy
  • cancer staging
  • computer assisted tomography
  • disease eradication
  • drug response
  • endoscopic ultrasonography
  • follow up
  • gastric marginal zone lymphoma
  • Helicobacter infection
  • human
  • marginal zone lymphoma
  • molecular biology
  • monoclonal b cell lymphocytosis
  • nodal marginal zone lymphoma
  • nuclear magnetic resonance imaging
  • outcome assessment
  • pathology
  • personalized medicine
  • positron emission tomography
  • practice guideline
  • priority journal
  • prognosis
  • recurrent disease
  • risk assessment
  • splenectomy
  • splenic marginal zone lymphoma
  • Follow-Up Studies
  • Humans
  • Lymphoma, B-Cell, Marginal Zone

Cite this